Similarly, in the kidney, a recent report showed that cisplatin-induced kidney damage and associated inflammatory responses were reduced following maltol pretreatment which reduced the activated PI3K-AKT signaling pathway [61]. The gene discussed is AKT1; the disease is Nephropathy.